Clinical Trials Browser

OTHER × Melanoma × GSK2141795 × Clear all

NCT01941927 2020-02-12

Trametinib With GSK2141795 in BRAF Wild-type Melanoma

Phase 2 Completed

20 enrolled 16 charts

Melanoma